Safety, Tolerability, Pharmacokinetics, and Food Effects on TAC‐302 in Healthy Participants: Randomized, Double‐Blind, Placebo‐Controlled, Single‐Dose and Multiple‐Dose Studies-Reference-Cited by-同舟云学术

Safety, Tolerability, Pharmacokinetics, and Food Effects on TAC‐302 in Healthy Participants: Randomized, Double‐Blind, Placebo‐Controlled, Single‐Dose and Multiple‐Dose Studies

Published:2020-01-22 Issue:7 Volume:9 Page:821-832
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Sesoko Shogo¹,Huang Jinhong²,Okayama Takashige³,Nishida Erika⁴,Miyoshi Kazuhisa⁴

Affiliation:

1. Sosenkai Clinic Edogawa Mizue Edogawa‐ku Tokyo Japan

2. Pharmacovigilance Department Taiho Pharmaceutical Co. Ltd. Uchikanda Chiyoda‐ku Tokyo Japan

3. Pharmacokinetics Research Laboratories Taiho Pharmaceutical Co. Ltd. Okubo Tsukuba Ibaraki Japan

4. Clinical Development II Department Taiho Pharmaceutical Co. Ltd. Uchikanda Chiyoda‐ku Tokyo Japan

Funder

Taiho Pharmaceutical

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.776

Reference13 articles.

1. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society

2. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019

3. The other bladder syndrome: underactive bladder;Miyazato M;Rev Urol,2013

4. Detrusor Underactivity: The Current Concept of the Pathophysiology

5. Neurotrophic activity of 2,4,4-trimethyl-3-(15-hydroxypentadecyl)-2-cyclohexen-1-one in cultured central nervous system neurons

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical direction in the pharmacological and device management of refractory overactive bladder: the urge to develop new treatments;Expert Opinion on Pharmacotherapy;2022-08-31